Who owns Lexicon Pharmaceuticals?

Key details on Lexicon Pharmaceuticals (Ticker: LXRX)

Who owns Lexicon Pharmaceuticals?

Is LXRX a good stock to own? Find out who bought Lexicon Pharmaceuticals, who sold Lexicon Pharmaceuticals (LXRX) stock, and who holds a large position in Lexicon Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Artal Group S.A. 402.63M $366.39M Dec. 31, 2014
FMR 77.22M $108.88M Sept. 30, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 34.44M $31.34M Dec. 31, 2014
Ulys 30.25M $27.53M Dec. 31, 2014
Vanguard 17.84M $16.24M Dec. 31, 2014
NEA Management Company 16.68M $15.18M Dec. 31, 2014
BlackRock Fund Advisors 12.38M $11.26M Dec. 31, 2014
Masters Capital Mgmt 8.00M $7.28M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 7.66M $6.97M Dec. 31, 2014
T. Rowe Price Associates 6.07M $5.53M Dec. 31, 2014
Royce & Associates 4.23M $7.32M March 31, 2014
Invus Public Equities Advisors 3.89M $6.85M June 30, 2011
STATE STREET CORPORATION 3.75M $3.41M Dec. 31, 2014
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 3.71M $3.49M March 31, 2015
NORTHERN TRUST 3.26M $5.87M Dec. 31, 2013
Perceptive Advisors 3.20M $6.97M March 31, 2013
Schroder Investment Management 3.16M $5.08M June 30, 2014